MedPath

LAMPIT 30 MG COMPRIMIDOS

LAMPIT 30 MG COMPRIMIDOS

Pending
Register Number

89507

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jun 4, 2024

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89507
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

NIFURTIMOXActive
Quantity: 30 mg
Name: NIFURTIMOX

ATC CLASSIFICATION (3)

P01C
P01CC
P01CC01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.